The state of Florida currently has 46 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
Physiology, Imaging and Modeling of Essential Tremor
NCT03811405
Recruiting
This project aims to investigate novel ways to deliver brain stimulation to Essential Tremor (ET) patients by introducing software changes to their existing devices. The study team aims to investigate safety and efficacy of these new stimulation parameters in patients with ET.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
06/13/2023
Locations: UF Health at the University of Florida, Gainesville, Florida +1 locations
Conditions: Essential Tremor, Parkinson Disease, Dystonia
Register for Updates
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847
Recruiting
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Gender:
All
Ages:
All
Trial Updated:
05/26/2023
Locations: University of Miami Hospital, Miami, Florida +1 locations
Conditions: Movement Disorders, Parkinson Disease, Essential Tremor, Tremor, Dystonia, Primary Dystonia, Secondary Dystonia
Register for Updates
Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder
NCT05307770
Recruiting
The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/25/2023
Locations: Mayo Clinic Florida, Jacksonville, Florida
Conditions: Rapid Eye Movement Sleep Behavior Disorder, Parkinson Disease
Register for Updates
Telehealth in Lewy Body Dementia
NCT05014971
Recruiting
Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include rural residence, limited access to specialists, travel distance, limited awareness of resources, and physical, cognitive, and behavioral impairments making travel to appointments challenging. Delivering interdisciplinary care remotely using video technology has the potential to improve access to care for patients with LBD.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
04/14/2023
Locations: University of Florida, Gainesville, Florida
Conditions: Lewy Body Dementia With Behavioral Disturbance, Lewy Body Parkinson Disease, Lewy Body Disease
Register for Updates
Rock Steady Boxing: A Community Based In Person Class
NCT05773612
Recruiting
The purpose of this study is to evaluate the feasibility and effectiveness of a non-contact Rock Steady Boxing class delivered to participants with Parkinson's Disease via an in-person community-based program. The study will also assess the overall feasibility of integrating an in-person community program within a neuromuscular course in a Doctor of Physical Therapy program. Specific Aim: To examine the effects of an in-person community-based Rock Steady Boxing class on the functional mobility,... Read More
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
03/06/2023
Locations: University of St Augustine for Health Science, Miami, Florida
Conditions: Parkinson Disease
Register for Updates
Longitudinal Cognitive Assessment by BoCA
NCT04114994
Recruiting
The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
Gender:
All
Ages:
50 years and above
Trial Updated:
01/31/2023
Locations: Andrey Vyshedskiy, Miami, Florida
Conditions: Alzheimer Disease, Mild Cognitive Impairment, Vascular Dementia, Frontotemporal Dementia, Parkinson Disease, Multiple Sclerosis, TBI
Register for Updates
Outcomes Mandate National Integration With Cannabis as Medicine
NCT03944447
Recruiting
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Gender:
All
Ages:
7 years and above
Trial Updated:
05/29/2022
Locations: OMNI Medical Services, Boca Raton, Florida +11 locations
Conditions: Chronic Pain, Chronic Pain Syndrome, Chronic Pain Due to Injury, Chronic Pain Due to Trauma, Fibromyalgia, Seizures, Hepatitis C, Cancer, Crohn Disease, HIV/AIDS, Multiple Sclerosis, Traumatic Brain Injury, Sickle Cell Disease, Post Traumatic Stress Disorder, Tourette Syndrome, Ulcerative Colitis, Glaucoma, Epilepsy, Inflammatory Bowel Diseases, Parkinson Disease, Amyotrophic Lateral Sclerosis, Chronic Traumatic Encephalopathy, Anxiety, Depression, Insomnia, Autism, Opioid-use Disorder, Bipolar Disorder, Covid19, SARS-CoV Infection, COVID-19, Corona Virus Infection, Coronavirus
Register for Updates
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
NCT04857359
Recruiting
This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placebo) for 12 weeks (1 week at 150 mg per day and 11 weeks at 300 mg per day). The primary efficacy assessment will be based on the Unified Dyskinesia Rating Scale (UDysRS). Patients who complete the 12-week blinded treatment period may have the option to roll into an open-label safety extension study for an additional 12-month treatment period.
Gender:
All
Ages:
Between 30 years and 85 years
Trial Updated:
05/18/2022
Locations: Parkinson's Disease and Movement Disorders Center of Boca Raton Inc, Boca Raton, Florida +6 locations
Conditions: Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias
Register for Updates
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
NCT05266417
Recruiting
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Gender:
All
Ages:
Between 30 years and 85 years
Trial Updated:
04/21/2022
Locations: Institute for Neuroimmune Medicine, Davie, Florida
Conditions: Parkinson Disease
Register for Updates
Parkinson's Foundation Surveys
NCT05066763
Recruiting
Parkinson's Foundation Surveys is an initiative seeking to periodically survey people with Parkinson's disease (PD), their care partners and medical professionals to better understand specific aspects of living with PD.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/23/2021
Locations: Parkinson's Foundation, Miami, Florida
Conditions: Parkinson Disease
Register for Updates